Nametso Kelentse, Sikhulile Moyo, Mompati L Mogwele, Doreen Ditshwanelo, Baitshepi Mokaleng, Natasha O Moraka, Kwana Lechiile, Tshepo B Leeme, David S Lawrence, Rosemary Musonda and 4 more
Article in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors at 6 institutions in 4 countries.
Nametso KelentseBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.ORCID 0000-0003-2433-2416
Sikhulile MoyoBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Mompati L MogweleBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Doreen DitshwaneloBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Baitshepi MokalengBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Natasha O MorakaBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Kwana LechiileBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Tshepo B LeemeBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
David S LawrenceBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.ORCID 0000-0002-5439-4039
Rosemary MusondaBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Ishmael KasvosveSchool of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.ORCID 0000-0002-2046-545X
Thomas S HarrisonCentre for Global Health, Institute for Infection and Immunity, St. George's University of London, London SW17 0RE, UK.
Joseph N JarvisBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Simani GaseitsiweBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
University of Botswana · BWHarvard University · USUniversity of London · GBBotswana Harvard AIDS Institute Partnership · BWStellenbosch University · ZASt George's, University of London · GB
Funding
Training in HIV Genomics, Treatment, and Cure Research in BotswanaD43TW009610 · FIC · THE BOTSWANA HARVARD HEALTH PARTNERSHIP · PI SHAHIN LOCKMAN, Joseph Moeketsi Makhema · 2013 to 2026
$4.4M
Department of Health RP-2017-08-ST2-012Medical Research Council MC_PC_MR/P006922/1Wellcome Trust 107752/Z/15/Z
6 · The paper itself
Abstract
HIV-1 compartmentalization in reservoir sites remains a barrier to complete HIV eradication. It is unclear whether there is variation in HIV-1
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.